Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Shared vision for primary care delivery and research in Canada and the United States: Highlights from the cross-border symposium.

Tamblyn R, Meyers D, Kratzmann M, Bazemore A, Bierman AS, Bindman AB, Hogg W, Price D, Rowe BH, Roy D, Steinberg J, Reid RH.

Can Fam Physician. 2018 Dec;64(12):930-934. No abstract available.

2.

Diagnosis by peritoneal scintigraphy of peritoneal dialysis-associated hydrothorax in an infant.

Chavannes M, Sharma AP, Singh RN, Reid RH, Filler G.

Perit Dial Int. 2014 Jan-Feb;34(1):140-3. doi: 10.3747/pdi.2012.00077. No abstract available.

3.

SPECT-based functional lung imaging for the prediction of radiation pneumonitis: a clinical and dosimetric correlation.

Hoover DA, Reid RH, Wong E, Stitt L, Sabondjian E, Rodrigues GB, Jaswal JK, Yaremko BP.

J Med Imaging Radiat Oncol. 2014 Apr;58(2):214-22. doi: 10.1111/1754-9485.12145. Epub 2013 Dec 25.

PMID:
24373453
4.

Sci-Fri AM: Imaging - 04: SPECT-based functional lung imaging in the prediction of radiation pneumonitis: A retrospective clinical and dosimetric correlation.

Hoover D, Reid RH, Rodrigues G, Wong E, Stitt L, Yaremko BP.

Med Phys. 2012 Jul;39(7Part4):4640-4641. doi: 10.1118/1.4740190.

PMID:
28516660
5.

Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.

Munawar I, Yaremko BP, Craig J, Oliver M, Gaede S, Rodrigues G, Yu E, Reid RH, Leung E, Urbain JL, Chen J, Wong E.

Med Phys. 2010 Apr;37(4):1863-72.

PMID:
20443508
6.

Electronic medical records: why today?

Reid RH.

Compr Ther. 2006 Fall;32(3):138-43. No abstract available.

PMID:
17435264
7.

Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.

Sartor O, Reid RH, Bushnell DL, Quick DP, Ell PJ.

Cancer. 2007 Feb 1;109(3):637-43.

8.

Prolonged deficits after focal inhibitory seizures.

Bussière M, Pelz D, Reid RH, Young GB.

Neurocrit Care. 2005;2(1):29-37.

PMID:
16174965
9.

Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.

Sartor O, Reid RH, Hoskin PJ, Quick DP, Ell PJ, Coleman RE, Kotler JA, Freeman LM, Olivier P; Quadramet 424Sm10/11 Study Group.

Urology. 2004 May;63(5):940-5.

PMID:
15134985
10.

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.

Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA.

J Clin Oncol. 1998 Apr;16(4):1574-81.

PMID:
9552068
11.

Pulmonary uptake of technetium-99m-sestamibi induced by dipyridamole-based stress or exercise.

Hurwitz GA, Ghali SK, Husni M, Slomka PJ, Mattar AG, Reid RH, Lefcoe NM.

J Nucl Med. 1998 Feb;39(2):339-45.

12.

Linear epitopes of colonization factor antigen I and peptide vaccine approach to enterotoxigenic Escherichia coli.

Cassels FJ, Jarboe DL, Reid RH, Lees A, Deal CD.

J Ind Microbiol Biotechnol. 1997 Jul;19(1):66-70.

PMID:
9281854
13.

The cortical representation of somatosensory evoked potentials of the phrenic nerve.

Zifko UA, Slomka PJ, Reid RH, Young GB, Remtulla H, Bolton CF.

J Neurol Sci. 1996 Aug;139(2):197-202.

PMID:
8856653
14.
15.

Declaring pediatric brain death: current practice in a Canadian pediatric critical care unit.

Parker BL, Frewen TC, Levin SD, Ramsay DA, Young GB, Reid RH, Singh NC, Gillett JM.

CMAJ. 1995 Oct 1;153(7):909-16.

16.
17.

Biomechanics for preoperative planning and surgical simulations in orthopaedics.

O'Toole RV 3rd, Jaramaz B, DiGioia AM 3rd, Visnic CD, Reid RH.

Comput Biol Med. 1995 Mar;25(2):183-91.

PMID:
7554836
18.

Intraduodenal immunization with microencapsulated CFA/II induces a delayed, anti-CFA/II, IgG antibody-secreting spleen cell response.

Sau K, Reid RH, McQueen C, Boedeker EC, Nellore R, Dalal P, Bhagat HR.

Adv Exp Med Biol. 1995;371B:1469-74. No abstract available.

PMID:
7502839
19.

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.

Tacket CO, Reid RH, Boedeker EC, Losonsky G, Nataro JP, Bhagat H, Edelman R.

Vaccine. 1994 Nov;12(14):1270-4.

PMID:
7856290
20.

Heavy-particle excitation of fluorinelike Fe XVIII.

Foster VJ, Keenan FP, Reid RH.

Phys Rev A. 1994 Apr;49(4):3092-3095. No abstract available.

PMID:
9910596
21.

Usefulness of (Tc 99m) HM-PAO scan in supporting clinical brain death in children: uncoupling flow and function.

Singh NC, Reid RH, Loft JA, Frewen TC, Parker BL, Dhillon JS.

Clin Intensive Care. 1994;5(2):71-4.

PMID:
10147256
22.

Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli.

Reid RH, Boedeker EC, McQueen CE, Davis D, Tseng LY, Kodak J, Sau K, Wilhelmsen CL, Nellore R, Dalal P, et al.

Vaccine. 1993;11(2):159-67.

PMID:
8438614
24.
25.

Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis.

Feild JA, Reid RH, Rieman DJ, Kline TP, Sathe G, Greig RG, Anzano MA.

Biochem J. 1992 Apr 1;283 ( Pt 1):91-8.

26.

Differential renal uptake of 201Tl: requirements for acquisition, display and quantification.

Hurwitz GA, Powe JE, Mattar AG, Reid RH, Driedger AA, Rendak I, Hogendoorn P.

Nucl Med Commun. 1991 Oct;12(10):885-99.

PMID:
1792024
27.

Cerebral perfusion imaging with technetium-99m HMPAO following cerebral trauma. Initial experience.

Reid RH, Gulenchyn KY, Ballinger JR, Ventureyra EC.

Clin Nucl Med. 1990 Jun;15(6):383-8.

PMID:
2354575
28.

In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.

Ecclestone M, Proulx A, Ballinger JR, Gerson B, Reid RH, Gulenchyn KY.

Eur J Nucl Med. 1990;16(4-6):299-302.

PMID:
2161770
29.

Radiopharmaceutical factors in the variable quality of [99mTc]HM-PAO images of the brain.

Ballinger JR, Gulenchyn KY, Reid RH.

J Nucl Med. 1990 Jan;31(1):118-22.

30.

Clinical use of technetium-99m HM-PAO for determination of brain death.

Reid RH, Gulenchyn KY, Ballinger JR.

J Nucl Med. 1989 Oct;30(10):1621-6.

31.

Computer simulations of a tumor surface octapeptide epitope.

Reid RH, Hooper CA, Brooks BR.

Biopolymers. 1989 Jan;28(1):525-30.

PMID:
2470439
32.

Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathione.

Ballinger JR, Reid RH, Gulenchyn KY.

J Nucl Med. 1988 Dec;29(12):1998-2000.

33.

Radiochemical purity of [99mTc]HM-PAO.

Ballinger JR, Reid RH, Gulenchyn KY.

J Nucl Med. 1988 Apr;29(4):572-3. No abstract available.

34.

Subarachnoid-pleural fistula complicating thoracotomy: case report and review of the literature.

Da Silva VF, Shamji FM, Reid RH, del Carpio-O'Donovan R.

Neurosurgery. 1987 May;20(5):802-5.

PMID:
3037431
35.

Rabbit ileal lamina propria (LP) lymphocytes give poor blastogenic responses to KLH immunization and concanavalin A mitogenesis.

Brewer TG, Reid RH, Hooper CA, McCarthy WT.

Adv Exp Med Biol. 1987;216A:497-504. No abstract available.

PMID:
3687536
36.

Isolation and characterization of rabbit ileal lamina propria mononuclear cells.

Hooper CA, Reid RH, Brewer TG, McCarthy WT.

Adv Exp Med Biol. 1987;216A:493-6. No abstract available.

PMID:
3687535
37.

N-terminal ten amino acid sequence determined for B-cell differentiation factor derived from rabbit breast milk cell supernatant.

Reid RH, Axelrod DA, Tseng LY, McCarthy WT, Hooper CA, Chung RC, Seid RC.

Adv Exp Med Biol. 1987;216A:191-6. No abstract available.

PMID:
3500573
38.

Recurrent gastrointestinal bleeding from jejunal duplication.

Papoff W, Reid RH.

Clin Nucl Med. 1986 Nov;11(11):754-5.

PMID:
3491719
39.
40.

Pediatric digital subtraction angiography.

Amundson GM, Wesenberg RL, Mueller DL, Reid RH.

Radiology. 1984 Dec;153(3):649-54.

PMID:
6387787
41.

Radionuclide assessment in nocturnal asthma.

Greyson ND, Reid RH, Liu YC, Thomas P.

Clin Nucl Med. 1982 Jul;7(7):318-9. No abstract available.

PMID:
7094495
42.

Primary neuroblastoma uptake of 99mtechnetium methylene diphosphonate.

Smith FW, Gilday DL, Ash JM, Reid RH.

Radiology. 1980 Nov;137(2):501-4.

PMID:
6449027
43.

Lack of oncogenicity with immunosuppressive therapy.

Pirofsky B, Dawson PJ, Reid RH.

Cancer. 1980 Apr 15;45(8):2096-101.

PMID:
6989484
44.

Myasthenia gravis treated with purified antithymocyte antiserum.

Pirofsky B, Reid RH, Bardana EJ Jr, Baker RL.

Neurology. 1979 Jan;29(1):112-6.

PMID:
311448
45.

The effect of adenosine on mitogenesis of ADA-deficient lymphocytes.

Uberti J, Lightbody JJ, Wolf JW, Anderson JA, Reid RH, Johnson RM.

Clin Immunol Immunopathol. 1978 Aug;10(4):446-58. No abstract available.

PMID:
688701
46.

Antithymocyte antiserum therapy in myasthenia gravis.

Pirofsky B, Reid RH, Bardana EJ Jr, Baker RL.

Postgrad Med J. 1976;52(5 Suppl):112-7.

PMID:
1087017
47.

The influence of immunosuppression and allografting on virus-induced lymphatic leukemia in mice.

Reid RH, Pirofsky B, Dawson PJ.

Transplantation. 1972 Feb;13(2):61-5. No abstract available.

PMID:
4333837
48.

Antithymocyte antisera theapy in nonsurgical immunologic disease.

Pirofsky B, Reid RH, Bardana EJ Jr, Bayrakci C.

Transplant Proc. 1971 Mar;3(1):769-72. No abstract available.

PMID:
4999470
49.

Isotope lung scanning in pediatric respiratory disease.

Reid RH.

Calif Med. 1970 May;112(5):66-7. No abstract available.

50.

Pulmonary leiomyoma.

Reid RH.

Calif Med. 1970 May;112(5):63-4. No abstract available.

Supplemental Content

Support Center